A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer

Breast Cancer. 2015 Nov;22(6):615-25. doi: 10.1007/s12282-014-0528-0. Epub 2014 Apr 10.

Abstract

Background: We performed this meta-analysis study to evaluate the concordance and discordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in detecting HER2 alteration in human breast cancer.

Methods: As a meta-analysis, the present study evaluated the available data from previous studies on the HER2 gene detected by IHC and FISH. To indicate the meta-analysis results, a forest plot was used.

Results: We identified 172 citations, for which our inclusion criteria were met by 18 articles, representing 6629 cases. The overall concordance and discordance rate between IHC staining with score 0/1+ and FISH for detection failure of HER2 expression was 96 and 4 %, respectively. The present study showed that the overall proportion of FISH positive and negative rate for IHC score 2+ for detection of HER2 expression was 36 and 64 %, respectively; and 91 and 9 % for 3+ IHC scores.

Conclusion: The results of this study show that IHC score 0/1+ and 3+ cannot be completely considered as negative and positive breast cancer test, respectively. Therefore, we suggest a valid and complementary test, the same as FISH, to explore HER2 expression.

Keywords: Breast cancer; Fluorescence in situ hybridization; HER2; Immunohistochemistry; Meta-analysis.

Publication types

  • Meta-Analysis

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • False Negative Reactions
  • False Positive Reactions
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry / methods*
  • In Situ Hybridization, Fluorescence / methods*
  • Receptor, ErbB-2 / genetics*
  • Receptor, ErbB-2 / metabolism*
  • Sensitivity and Specificity

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2